米国企業
Travere Therapeutics, Inc.

Travere Therapeutics, Inc.TVTX

時価総額

$11.5億

PER

	2012年 2月29日	2012年 12月31日	2013年 12月31日	2014年 12月31日	2015年 12月31日	2016年 12月31日	2017年 12月31日	2018年 12月31日	2019年 12月31日	2020年 12月31日	2021年 12月31日	2022年 12月31日	2023年 12月31日
Cash and cash equivalents	-	11,388	6	-	38	41	99	103	62	85	166	62	58
Debt Securities, Available-for-Sale	-	-	-	-	-	-	-	369	336	277	387	389	509
Accounts receivable, net	-	-	-	-	12	19	14	14	18	16	16	17	21
Inventory, net	-	-	-	-	3	3	5	6	6	8	7	7	9
Prepaid expenses and other current assets	-	-	1	-	2	5	3	2	5	8	6	13	19
Total current assets	-	33,218	8	-	302	332	326	496	429	410	583	486	617
Total current assets	-	33,218	8	-	302	332	326	496	429	410	583	486	617
Property and equipment, net	-	23,790	127,427	-	0	3	3	3	3	9	11	9	7
Inventory, Noncurrent	-	-	-	-	-	-	-	-	-	-	-	-	31
Operating lease right of use assets	-	-	-	-	-	-	-	-	-	-	23	21	18
Property and equipment, net	-	23,790	127,427	-	0	3	3	3	3	9	11	9	7
Intangible assets, net	-	-	-	-	-	182	185	187	157	153	148	145	104
Operating lease right of use assets	-	-	-	-	-	-	-	-	-	-	23	21	18
Other assets	-	-	-	-	2	7	6	8	15	33	11	11	11
Intangible assets, net	-	-	-	-	-	182	185	187	157	153	148	145	104
Total assets	-	2	20	-	512	525	520	709	605	607	777	673	789
Other assets	-	-	-	-	2	7	6	8	15	33	11	11	11
Total assets	-	2	20	-	512	525	520	709	605	607	777	673	789
Accounts payable	-	1	4	-	8	8	19	7	27	12	15	17	42
Accrued expenses	66,989	2	3	-	24	33	36	50	52	57	75	96	119
Deferred revenue, current portion	-	-	-	-	-	-	-	-	-	-	16	12	7
Business Combination, Contingent Consideration, Liability, Current	-	-	-	-	-	-	-	-	-	-	7	7	-
Operating Lease, Liability, Current	-	-	-	-	-	-	-	-	-	-	4	4	5
Other current liabilities	-	-	-	-	1	2	4	4	9	6	6	6	5
Total current liabilities	-	6	35	-	86	83	86	105	95	93	124	142	178
Accounts payable	-	1	4	-	8	8	19	7	27	12	15	17	42
Accrued expenses	66,989	2	3	-	24	33	36	50	52	57	75	96	119
Deferred revenue, current portion	-	-	-	-	-	-	-	-	-	-	16	12	7
Operating Lease, Liability, Current	-	-	-	-	-	-	-	-	-	-	4	4	5
Other current liabilities	-	-	-	-	1	2	4	4	9	6	6	6	5
Total current liabilities	-	6	35	-	86	83	86	105	95	93	124	142	178
Convertible debt	-	-	-	-	44	44	45	195	205	215	227	376	377
Deferred revenue, less current portion	-	-	-	-	-	-	-	-	-	-	20	11	2
Business Combination, Contingent Consideration, Liability, Noncurrent	-	-	-	-	-	-	-	-	-	-	60	64	-
Operating Lease, Liability, Noncurrent	-	-	-	-	-	-	-	-	-	-	31	28	23
Operating Lease, Liability, Noncurrent	-	-	-	-	-	-	-	-	-	-	31	28	23
Other non-current liabilities	-	-	-	-	3	4	2	4	21	41	12	9	8
Other non-current liabilities	-	-	-	-	3	4	2	4	21	41	12	9	8
Total liabilities	-	6	39	-	212	218	227	391	384	396	475	630	588
Preferred Stock, Value, Issued	-	-	-	-	-	-	-	-	-	-	-	-	-
Common Stock, Value, Issued	-	895	1,855	-	0	0	0	0	0	0	0	0	0
Additional paid-in capital	72,989	30	50	-	366	421	472	590	637	798	1,069	1,060	1,328
Accumulated deficit	-136,081	-	-	-	-65	-113	-178	-270	-416	-586	-766	-1,014	-1,126
Accumulated other comprehensive loss	-	-	-109,987	-	-1	-0	-1	-2	1	-1	-1	-3	-1
Total stockholders' equity	-63,080	-3,407,815	-18,311,898	-	300	308	293	318	221	211	302	43	201
Total liabilities and stockholders' equity	3	2	20	-	512	525	520	709	605	607	777	673	789